lidocaine has been researched along with Cardiovascular Diseases in 31 studies
Lidocaine: A local anesthetic and cardiac depressant used as an antiarrhythmia agent. Its actions are more intense and its effects more prolonged than those of PROCAINE but its duration of action is shorter than that of BUPIVACAINE or PRILOCAINE.
lidocaine : The monocarboxylic acid amide resulting from the formal condensation of N,N-diethylglycine with 2,6-dimethylaniline.
Cardiovascular Diseases: Pathological conditions involving the CARDIOVASCULAR SYSTEM including the HEART; the BLOOD VESSELS; or the PERICARDIUM.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Four hundred two patients with suspected myocardial infarction seen within 6 hours of the onset of symptoms entered a double-blind randomized trial of lidocaine vs placebo." | 9.05 | Prophylactic lidocaine in the early phase of suspected myocardial infarction. ( Adgey, AA; Campbell, NP; Dunn, HM; Kinney, CD; MacKenzie, G; McComb, JM; Shanks, RG, 1985) |
| "The routine use of fentanyl and midazolam prior to sheath removal leads to a reduction in pain perception and vasovagal incidence, whilst the routine use of local infiltration during sheath removal should be discouraged as it leads to more pain and a trend to more vasovagal reactions." | 5.12 | Effect of local anesthesia and intravenous sedation on pain perception and vasovagal reactions during femoral arterial sheath removal after percutaneous coronary intervention. ( French, JK; Juergens, CP; Kiat Ang, C; Leung, DY; Lo, S, 2007) |
| "Four hundred two patients with suspected myocardial infarction seen within 6 hours of the onset of symptoms entered a double-blind randomized trial of lidocaine vs placebo." | 5.05 | Prophylactic lidocaine in the early phase of suspected myocardial infarction. ( Adgey, AA; Campbell, NP; Dunn, HM; Kinney, CD; MacKenzie, G; McComb, JM; Shanks, RG, 1985) |
| "Lidocaine 2% was administered to eight dogs before surgery in differing amounts, depending on the volume of the joints involved, and blood samples were taken at predetermined time points." | 2.80 | Intra-articular administration of lidocaine in anaesthetized dogs: pharmacokinetic profile and safety on cardiovascular and nervous systems. ( Bufalari, A; Cagnardi, P; Catanzaro, A; De Monte, V; Della Rocca, G; Di Salvo, A; Marenzoni, ML; Vigorito, V, 2015) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 17 (54.84) | 18.7374 |
| 1990's | 1 (3.23) | 18.2507 |
| 2000's | 7 (22.58) | 29.6817 |
| 2010's | 5 (16.13) | 24.3611 |
| 2020's | 1 (3.23) | 2.80 |
| Authors | Studies |
|---|---|
| Zhu, K | 1 |
| Yan, T | 1 |
| Qin, C | 1 |
| Pan, Y | 1 |
| Li, J | 1 |
| Lai, H | 1 |
| Xu, D | 1 |
| Wang, C | 1 |
| Hu, N | 1 |
| Di Salvo, A | 1 |
| Bufalari, A | 1 |
| De Monte, V | 1 |
| Cagnardi, P | 1 |
| Marenzoni, ML | 1 |
| Catanzaro, A | 1 |
| Vigorito, V | 1 |
| Della Rocca, G | 1 |
| Dadak, AM | 1 |
| Franz, S | 1 |
| Jäger, W | 1 |
| Tichy, A | 1 |
| Baumgartner, W | 1 |
| Mosing, M | 1 |
| Dobson, GP | 1 |
| Pham, DT | 1 |
| Castello, R | 1 |
| Hammon, JW | 1 |
| Wolfe, JW | 1 |
| Butterworth, JF | 1 |
| Lotufo, PA | 1 |
| WELFLING, J | 1 |
| Breunig, J | 1 |
| Kiat Ang, C | 1 |
| Leung, DY | 1 |
| Lo, S | 1 |
| French, JK | 1 |
| Juergens, CP | 1 |
| Gunnar, RM | 1 |
| Lambrew, CT | 1 |
| Abrams, W | 1 |
| Adolph, RJ | 1 |
| Chatterjee, K | 1 |
| Cohn, JN | 1 |
| Derryberry, JS | 1 |
| Horowitz, LN | 1 |
| Martin, WB | 1 |
| Siciliano, EG | 1 |
| Temple, R | 1 |
| Tuckman, J | 1 |
| Drake, CE | 1 |
| Caride, VJ | 1 |
| Bunting, HE | 1 |
| Kelly, MC | 1 |
| Milligan, KR | 1 |
| Caron, MF | 1 |
| Song, J | 1 |
| White, CM | 1 |
| Singh, BN | 1 |
| Niwa, H | 1 |
| Sugimura, M | 1 |
| Satoh, Y | 1 |
| Tanimoto, A | 1 |
| Guntheroth, W | 1 |
| Whitcomb, DC | 1 |
| Gilliam, FR | 1 |
| Starmer, CF | 1 |
| Grant, AO | 1 |
| Covino, BG | 1 |
| Yang, MW | 1 |
| Lee, TY | 1 |
| Chan, KH | 1 |
| Chung, SK | 1 |
| Dunn, HM | 1 |
| McComb, JM | 1 |
| Kinney, CD | 1 |
| Campbell, NP | 1 |
| Shanks, RG | 1 |
| MacKenzie, G | 1 |
| Adgey, AA | 1 |
| Cantele, P | 1 |
| Manani, G | 1 |
| Cirillo, FM | 1 |
| Pizzirani, E | 1 |
| Bortoluzzi, A | 1 |
| Hendrix, GH | 1 |
| Cline, ME | 1 |
| Raisfeld, IH | 1 |
| Thomson, PD | 1 |
| Geddes, IC | 1 |
| Slama, R | 1 |
| Motte, G | 1 |
| Gourgon, R | 1 |
| Passa, P | 1 |
| Bouvrain, Y | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Fractional Carbon Dioxide Laser Assisted Delivery of Topical Anesthetics: a Randomized Controlled Pilot Study[NCT02246179] | Phase 4 | 10 participants (Actual) | Interventional | 2014-09-30 | Completed | ||
| Parameters in Fractional Laser Assisted Delivery of Topical Anesthetics: Role of Anesthetic and Application Time[NCT03279757] | Phase 4 | 15 participants (Actual) | Interventional | 2016-10-01 | Completed | ||
| Parameters in Fractional Laser Assisted Delivery of Topical Anesthetics: Role of Laser Type and Laser Settings[NCT02938286] | Phase 4 | 15 participants (Actual) | Interventional | 2016-03-31 | Completed | ||
| Fractional CO2 Laser Assisted Topical Articaine Anesthesia vs. Topical EMLA Administration: a Randomized Controlled Study[NCT02548533] | Phase 4 | 3 participants (Actual) | Interventional | 2015-06-30 | Terminated (stopped due to Not enough patients eligible for recruitment.) | ||
| Prospective Randomized Trial of Penile Nerve Block With Liposomal Bupivacaine for Hypospadias Repair vs Standard Penile Block With Bupivacaine[NCT04479371] | Phase 1 | 0 participants (Actual) | Interventional | 2021-07-31 | Withdrawn (stopped due to Limited funding and resources to complete FDA requirements for enrollment) | ||
| Use of Preemptive Pudendal Nerve Block Prior to Hydrodistension for the Treatment of Interstitial Cystitis/Painful Bladder Syndrome (IC/PBS): a Prospective, Double-blinded, Randomized Control Trial[NCT02517996] | 18 participants (Actual) | Interventional | 2015-02-28 | Terminated (stopped due to Preliminary results were promising when interim analysis performed but terminated due to primary investigators left recruitment site.) | |||
| Maternal-Fetal Monitoring of Patients With Rheumatic Heart Disease During Dental Procedure Under Local Anesthesia[NCT00482573] | Phase 1 | 31 participants (Actual) | Interventional | 2004-04-30 | Completed | ||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
"To determine the change in interstitial cystitis symptom index at baseline, 2 hours, 2 weeks, 6 weeks and 3 months after hydrodistention with preemptive pudendal nerve block (1% Lidocaine) compared to hydrodistention with placebo (saline).~The IC symptom index questionnaire consists of 4 questions on IC symptoms. 2 of the questions have 6 answer choices ranging from 0-never, to 5-almost always. 1 question has 6 answer choices ranging from 0-never to 5-usually. 1 question has 7 answer choices ranging from 0-never to 6-5 or more times. The numerical score for each question are added together, with a minimum score of 0 and a maximum score of 21. A higher score indicates greater severity of IC symptoms." (NCT02517996)
Timeframe: Baseline, 2 weeks, 6 weeks, 3 months (Up to 3 months)
| Intervention | score on a scale (Mean) | |||
|---|---|---|---|---|
| Baseline | 2 weeks | 6 weeks | 12 weeks | |
| 1% Lidocaine | 12.5 | 11.43 | 11.8 | 10 |
| Normal Saline | 10 | 9 | 8.67 | 5 |
"To determine the change in pain at 2 hours, 2 weeks, 6 weeks, and 3 months postoperatively in patients undergoing hydrodistention with preemptive pudendal nerve block (1% Lidocaine) compared to hydrodistention with placebo (saline) using the visual analog scale (VAS).~VAS consists of a 10cm horizontal line with the minimum endpoint labeled no pain (0) and maximum labeled worst pain ever (10). Patients placed a mark on the point that corresponds to the level of pain severity they felt. The cm distance from the low end of the VAS to the patient's mark is used as the numerical index of the intensity of pain. Pain scores of 3.0-5.4 cm are moderate, over 5.4 indicates severe pain." (NCT02517996)
Timeframe: Baseline, 2 hours, 2 weeks, 6 weeks, 3 months (Up to 3 months)
| Intervention | score on a scale (Mean) | ||||
|---|---|---|---|---|---|
| Pre operative VAS score | Post operative VAS score | 2 week post operative VAS scores | 6 week post operative VAS score | 12 weeks post operative VAS score | |
| 1% Lidocaine | 3.125 | 3.75 | 2.7 | 3 | 2.6 |
| Normal Saline | 4.5 | 5 | 4.8 | 4.33 | 2 |
"To determine the change in pelvic urgency, pain and frequency (PUF) questionnaire at baseline, 2 hours, 2 weeks, 6 weeks and 3 months after hydrodistention with preemptive pudendal nerve block (1% Lidocaine) compared to hydrodistention with placebo (saline).~The Pelvic Urgency, Pain, and Frequency Patient Symptom Scale asks 11 questions, 7 on PUF symptoms, 4 on how bothersome PUF symptoms are. Symptom questions include 3, 4, or 5 ranked answers, with higher answers indicating more voids, or greater frequency of pain. The bother questions each of 4 ranked answers from 0-never, to 3-always. The symptom score is added, the bother score is added, and then the total score is added. The total PUF score is then reported. The minimum score is 0 and the maximum score is 35, and a higher score indicates greater symptoms and higher bother from pelvic pain and frequency." (NCT02517996)
Timeframe: Baseline, 2 hours, 2 weeks, 6 weeks, 3 months (Up to 3 months)
| Intervention | score on a scale (Mean) | |||
|---|---|---|---|---|
| Baseline | 2 weeks | 6 weeks | 12 weeks | |
| 1% Lidocaine | 22.63 | 18.83 | 18.2 | 17.2 |
| Normal Saline | 19 | 17.4 | 16.7 | 14 |
"To determine the change in problem index (O'Leary Sant) at baseline, 2 hours, 2 weeks, 6 weeks and 3 months after hydrodistention with preemptive pudendal nerve block (1% Lidocaine) compared to hydrodistention with placebo (saline).~The IC problem index questionnaire consists of 4 questions on how much of a problem a patient's IC symptoms cause them. Each question has 5 answer choices ranging from 0-no problem, to 4-big problem. The numerical score for each question are added together, with a minimum score of 0 and a maximum score of 16. A higher score indicates that IC symptoms cause more problems for the patient." (NCT02517996)
Timeframe: Baseline, 2 hours, 2 weeks, 6 weeks, 3 months (Up to 3 months)
| Intervention | score on a scale (Mean) | |||
|---|---|---|---|---|
| Baseline | 2 weeks | 6 weeks | 12 weeks | |
| 1% Lidocaine | 11.75 | 9.71 | 10 | 9.6 |
| Normal Saline | 9.43 | 8.6 | 7.33 | 6 |
7 reviews available for lidocaine and Cardiovascular Diseases
| Article | Year |
|---|---|
[Topical anaesthesia in cataract surgery].
Topics: Aged; Anesthesia, Local; Anesthetics, Local; Anterior Chamber; Cardiovascular Diseases; Cataract Ext | 2010 |
Local anesthetic systemic toxicity: update on mechanisms and treatment.
Topics: Anesthesia, Local; Anesthetics, Local; Animals; Bupivacaine; Cardiovascular Diseases; Disease Models | 2011 |
Local anesthetic systemic toxicity: update on mechanisms and treatment.
Topics: Anesthesia, Local; Anesthetics, Local; Animals; Bupivacaine; Cardiovascular Diseases; Disease Models | 2011 |
Local anesthetic systemic toxicity: update on mechanisms and treatment.
Topics: Anesthesia, Local; Anesthetics, Local; Animals; Bupivacaine; Cardiovascular Diseases; Disease Models | 2011 |
Local anesthetic systemic toxicity: update on mechanisms and treatment.
Topics: Anesthesia, Local; Anesthetics, Local; Animals; Bupivacaine; Cardiovascular Diseases; Disease Models | 2011 |
Local anesthetic systemic toxicity: update on mechanisms and treatment.
Topics: Anesthesia, Local; Anesthetics, Local; Animals; Bupivacaine; Cardiovascular Diseases; Disease Models | 2011 |
Local anesthetic systemic toxicity: update on mechanisms and treatment.
Topics: Anesthesia, Local; Anesthetics, Local; Animals; Bupivacaine; Cardiovascular Diseases; Disease Models | 2011 |
Local anesthetic systemic toxicity: update on mechanisms and treatment.
Topics: Anesthesia, Local; Anesthetics, Local; Animals; Bupivacaine; Cardiovascular Diseases; Disease Models | 2011 |
Local anesthetic systemic toxicity: update on mechanisms and treatment.
Topics: Anesthesia, Local; Anesthetics, Local; Animals; Bupivacaine; Cardiovascular Diseases; Disease Models | 2011 |
Local anesthetic systemic toxicity: update on mechanisms and treatment.
Topics: Anesthesia, Local; Anesthetics, Local; Animals; Bupivacaine; Cardiovascular Diseases; Disease Models | 2011 |
Local anesthetic systemic toxicity: update on mechanisms and treatment.
Topics: Anesthesia, Local; Anesthetics, Local; Animals; Bupivacaine; Cardiovascular Diseases; Disease Models | 2011 |
Local anesthetic systemic toxicity: update on mechanisms and treatment.
Topics: Anesthesia, Local; Anesthetics, Local; Animals; Bupivacaine; Cardiovascular Diseases; Disease Models | 2011 |
Local anesthetic systemic toxicity: update on mechanisms and treatment.
Topics: Anesthesia, Local; Anesthetics, Local; Animals; Bupivacaine; Cardiovascular Diseases; Disease Models | 2011 |
Local anesthetic systemic toxicity: update on mechanisms and treatment.
Topics: Anesthesia, Local; Anesthetics, Local; Animals; Bupivacaine; Cardiovascular Diseases; Disease Models | 2011 |
Local anesthetic systemic toxicity: update on mechanisms and treatment.
Topics: Anesthesia, Local; Anesthetics, Local; Animals; Bupivacaine; Cardiovascular Diseases; Disease Models | 2011 |
Local anesthetic systemic toxicity: update on mechanisms and treatment.
Topics: Anesthesia, Local; Anesthetics, Local; Animals; Bupivacaine; Cardiovascular Diseases; Disease Models | 2011 |
Local anesthetic systemic toxicity: update on mechanisms and treatment.
Topics: Anesthesia, Local; Anesthetics, Local; Animals; Bupivacaine; Cardiovascular Diseases; Disease Models | 2011 |
Local anesthetic systemic toxicity: update on mechanisms and treatment.
Topics: Anesthesia, Local; Anesthetics, Local; Animals; Bupivacaine; Cardiovascular Diseases; Disease Models | 2011 |
Local anesthetic systemic toxicity: update on mechanisms and treatment.
Topics: Anesthesia, Local; Anesthetics, Local; Animals; Bupivacaine; Cardiovascular Diseases; Disease Models | 2011 |
Local anesthetic systemic toxicity: update on mechanisms and treatment.
Topics: Anesthesia, Local; Anesthetics, Local; Animals; Bupivacaine; Cardiovascular Diseases; Disease Models | 2011 |
Local anesthetic systemic toxicity: update on mechanisms and treatment.
Topics: Anesthesia, Local; Anesthetics, Local; Animals; Bupivacaine; Cardiovascular Diseases; Disease Models | 2011 |
Local anesthetic systemic toxicity: update on mechanisms and treatment.
Topics: Anesthesia, Local; Anesthetics, Local; Animals; Bupivacaine; Cardiovascular Diseases; Disease Models | 2011 |
Local anesthetic systemic toxicity: update on mechanisms and treatment.
Topics: Anesthesia, Local; Anesthetics, Local; Animals; Bupivacaine; Cardiovascular Diseases; Disease Models | 2011 |
Local anesthetic systemic toxicity: update on mechanisms and treatment.
Topics: Anesthesia, Local; Anesthetics, Local; Animals; Bupivacaine; Cardiovascular Diseases; Disease Models | 2011 |
Local anesthetic systemic toxicity: update on mechanisms and treatment.
Topics: Anesthesia, Local; Anesthetics, Local; Animals; Bupivacaine; Cardiovascular Diseases; Disease Models | 2011 |
Local anesthetic systemic toxicity: update on mechanisms and treatment.
Topics: Anesthesia, Local; Anesthetics, Local; Animals; Bupivacaine; Cardiovascular Diseases; Disease Models | 2011 |
Local anesthetic systemic toxicity: update on mechanisms and treatment.
Topics: Anesthesia, Local; Anesthetics, Local; Animals; Bupivacaine; Cardiovascular Diseases; Disease Models | 2011 |
Local anesthetic systemic toxicity: update on mechanisms and treatment.
Topics: Anesthesia, Local; Anesthetics, Local; Animals; Bupivacaine; Cardiovascular Diseases; Disease Models | 2011 |
Local anesthetic systemic toxicity: update on mechanisms and treatment.
Topics: Anesthesia, Local; Anesthetics, Local; Animals; Bupivacaine; Cardiovascular Diseases; Disease Models | 2011 |
Local anesthetic systemic toxicity: update on mechanisms and treatment.
Topics: Anesthesia, Local; Anesthetics, Local; Animals; Bupivacaine; Cardiovascular Diseases; Disease Models | 2011 |
Local anesthetic systemic toxicity: update on mechanisms and treatment.
Topics: Anesthesia, Local; Anesthetics, Local; Animals; Bupivacaine; Cardiovascular Diseases; Disease Models | 2011 |
Local anesthetic systemic toxicity: update on mechanisms and treatment.
Topics: Anesthesia, Local; Anesthetics, Local; Animals; Bupivacaine; Cardiovascular Diseases; Disease Models | 2011 |
Local anesthetic systemic toxicity: update on mechanisms and treatment.
Topics: Anesthesia, Local; Anesthetics, Local; Animals; Bupivacaine; Cardiovascular Diseases; Disease Models | 2011 |
Local anesthetic systemic toxicity: update on mechanisms and treatment.
Topics: Anesthesia, Local; Anesthetics, Local; Animals; Bupivacaine; Cardiovascular Diseases; Disease Models | 2011 |
Local anesthetic systemic toxicity: update on mechanisms and treatment.
Topics: Anesthesia, Local; Anesthetics, Local; Animals; Bupivacaine; Cardiovascular Diseases; Disease Models | 2011 |
Local anesthetic systemic toxicity: update on mechanisms and treatment.
Topics: Anesthesia, Local; Anesthetics, Local; Animals; Bupivacaine; Cardiovascular Diseases; Disease Models | 2011 |
Local anesthetic systemic toxicity: update on mechanisms and treatment.
Topics: Anesthesia, Local; Anesthetics, Local; Animals; Bupivacaine; Cardiovascular Diseases; Disease Models | 2011 |
Safe usage of lidocaine for liposuction.
Topics: Anesthetics, Local; Cardiovascular Diseases; Drug Interactions; Humans; Infusions, Parenteral; Lidoc | 2003 |
Task force IV: pharmacologic interventions. Emergency cardiac care.
Topics: Adrenergic beta-Antagonists; Analgesics, Opioid; Anti-Arrhythmia Agents; Atropine; Calcium Channel B | 1982 |
Recent advances in local anaesthesia.
Topics: Acidosis; Anesthesia, Local; Anesthetics, Local; Animals; Arrhythmias, Cardiac; Bupivacaine; Cardiov | 1986 |
Clinical pharmacology of drug interactions.
Topics: Antihypertensive Agents; Blood Coagulation Disorders; Cardiovascular Diseases; Coumarins; Drug Inter | 1973 |
Alteration in pharmacologic response induced by cardiovascular disease.
Topics: Cardiac Output; Cardiovascular Diseases; Coronary Vessels; Digitalis Glycosides; Half-Life; Heart; H | 1974 |
4 trials available for lidocaine and Cardiovascular Diseases
| Article | Year |
|---|---|
Intra-articular administration of lidocaine in anaesthetized dogs: pharmacokinetic profile and safety on cardiovascular and nervous systems.
Topics: Anesthesia, General; Anesthetics, Local; Animals; Area Under Curve; Cardiovascular Diseases; Central | 2015 |
Effect of local anesthesia and intravenous sedation on pain perception and vasovagal reactions during femoral arterial sheath removal after percutaneous coronary intervention.
Topics: Aged; Anesthetics, Local; Angioplasty, Balloon, Coronary; Bradycardia; Cardiovascular Diseases; Cons | 2007 |
Effect of nebulized lignocaine on airway irritation and haemodynamic changes during induction of anaesthesia with desflurane.
Topics: Adult; Anesthesia, Local; Anesthetics, Inhalation; Anesthetics, Local; Cardiovascular Diseases; Desf | 1995 |
Prophylactic lidocaine in the early phase of suspected myocardial infarction.
Topics: Adult; Aged; Arrhythmias, Cardiac; Brain Diseases; Cardiovascular Diseases; Clinical Trials as Topic | 1985 |
20 other studies available for lidocaine and Cardiovascular Diseases
| Article | Year |
|---|---|
Three-Dimensional Cardiomyocyte-Nanobiosensing System for Specific Recognition of Drug Subgroups.
Topics: Cardiovascular Diseases; Electroporation; Humans; Lidocaine; Myocytes, Cardiac | 2023 |
Pharmacokinetics and clinical efficacy of lidocaine in cattle after intranasal administration during rhinotracheobronchoscopy.
Topics: Administration, Intranasal; Anesthetics, Local; Animals; Bronchoscopy; Cardiovascular Diseases; Catt | 2009 |
Membrane polarity: a target for myocardial protection and reduced inflammation in adult and pediatric cardiothoracic surgery.
Topics: Adenosine; Adult; Anti-Arrhythmia Agents; Cardiac Surgical Procedures; Cardioplegic Solutions; Cardi | 2010 |
Why change?
Topics: Adenosine; Adult; Anti-Arrhythmia Agents; Cardiac Surgical Procedures; Cardioplegic Solutions; Cardi | 2010 |
After the hype, HOPE (and HPS): some lessons from the Women's Health Initiative trial, the Heart Outcomes Prevention Evaluation study and the Heart Prevention Study.
Topics: Anti-Arrhythmia Agents; Arteriosclerosis; Cardiovascular Diseases; Causality; Clinical Trials as Top | 2003 |
[PERIARTHRITIS OF THE SHOULDER AND CARDIOVASCULAR DISEASES].
Topics: Adrenal Cortex Hormones; Cardiovascular Diseases; Coronary Disease; Diagnosis; Humans; Lidocaine; My | 1963 |
Cardiac drug overdose.
Topics: Arrhythmias, Cardiac; Bretylium Compounds; Cardiovascular Agents; Cardiovascular Diseases; Digoxin; | 1982 |
Drug carriers in cardiovascular pharmacology.
Topics: Animals; Cardiovascular Diseases; Carrier Proteins; Dogs; Gangliosides; Humans; Lidocaine; Liposomes | 1980 |
Antiarrhythmic classifications in the 2000 Guidelines for Cardiopulmonary Resuscitation and Emergency Cardiovascular Care.
Topics: Anti-Arrhythmia Agents; Cardiopulmonary Resuscitation; Cardiovascular Diseases; Humans; Lidocaine; P | 2001 |
CIBIS, MERIT-HF, and COPERNICUS trial outcomes: do they complete the chapter on beta-adrenergic blockers as antiarrhythmic and antifibrillatory drugs?
Topics: Adrenergic beta-Antagonists; Anti-Arrhythmia Agents; Cardiovascular Diseases; Clinical Trials as Top | 2001 |
Cardiovascular response to epinephrine-containing local anesthesia in patients with cardiovascular disease.
Topics: Aged; Anesthesia, Dental; Anesthesia, Local; Anesthetics, Local; Blood Pressure; Cardiac Output; Car | 2001 |
Drugs used in the care of the cardiac patient.
Topics: Anticoagulants; Antihypertensive Agents; Arrhythmias, Cardiac; Atropine; Bretylium Tosylate; Cardiac | 1978 |
Neonatal and pediatric cardiovascular crises.
Topics: Animals; Arrhythmias, Cardiac; Blood Pressure; Bradycardia; Cardiovascular Diseases; Digoxin; Emerge | 1975 |
Marked QRS complex abnormalities and sodium channel blockade by propoxyphene reversed with lidocaine.
Topics: Adult; Cardiovascular Diseases; Cardiovascular System; Dextropropoxyphene; Electric Conductivity; El | 1989 |
Attenuation of circulatory response to laryngoscopy and tracheal intubation--a comparative study of different low doses of fentanyl with or without additional lidocaine in various regimens.
Topics: Adult; Aged; Anesthesia, Endotracheal; Cardiovascular Diseases; Fentanyl; Humans; Intubation, Intrat | 1985 |
[Cardiocirculatory responses to tracheal intubation in the heart patient].
Topics: Aerosols; Anesthesia, Endotracheal; Anesthesia, Local; Cardiovascular Diseases; Female; Fentanyl; He | 1985 |
Effects of an unusually large amount of intravenous lidocaine.
Topics: Cardiovascular Diseases; Hemodynamics; Humans; Injections, Intravenous; Lidocaine; Male; Middle Aged | 1972 |
Editorial: Vasoconstrictors in local anesthetic.
Topics: Anesthesia, Dental; Anesthesia, Local; Anesthetics; Antidepressive Agents; Cardiovascular Diseases; | 1973 |
Local anaesthetics.
Topics: Amides; Anesthetics, Local; Brain Edema; Cardiovascular Diseases; Central Nervous System Diseases; C | 1971 |
[Lignocaine is of no value in emergency treatment of stable ventricular tachycardia].
Topics: Adolescent; Adult; Aged; Cardiovascular Diseases; Electrocardiography; Humans; Injections, Intraveno | 1969 |